Deaths prostate cancer diagnostic imaging. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Cell Line Neoplastic Cells, Circulating Stromal Cells Cell Nucleus

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Mice, Inbred C57BL

Diseases35

Neoplasms Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Disease Progression Adenocarcinoma Neoplasm Metastasis Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Death Lung Neoplasms Carcinoma Neoplasm Recurrence, Local Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Pancreatic Neoplasms Prostatic Diseases Prostatitis Urinary Bladder Neoplasms Disease Models, Animal Colorectal Neoplasms Neovascularization, Pathologic Death, Sudden, Cardiac Uterine Cervical Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Brain Death Neoplastic Cells, Circulating Rectal Neoplasms

Chemicals and Drugs68

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists RNA, Messenger Anilides Dihydrotestosterone Finasteride RNA, Small Interfering Metribolone Flutamide Anticarcinogenic Agents Cancer Vaccines Taxoids Glutamate Carboxypeptidase II DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antigens, Neoplasm Antineoplastic Agents, Phytogenic Testosterone Congeners Proto-Oncogene Proteins c-akt Testosterone Tumor Suppressor Protein p53 Androstenols Nitriles 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Azasteroids Phenylthiohydantoin Transcription Factors Caspases Proto-Oncogene Proteins c-bcl-2 RNA, Neoplasm MicroRNAs Racemases and Epimerases Tumor Suppressor Proteins Cholestenone 5 alpha-Reductase DNA-Binding Proteins Antibodies, Monoclonal Proto-Oncogene Proteins Leuprolide Estramustine Receptor, erbB-2 Enzyme Inhibitors DNA Primers Goserelin Glutathione S-Transferase pi Receptors, Estrogen Caspase 3 Biological Markers Paclitaxel Kallikreins Oncogene Proteins, Fusion Radiopharmaceuticals Prostatic Secretory Proteins Androgen-Binding Protein Nuclear Proteins Steroid 17-alpha-Hydroxylase Membrane Proteins Ki-67 Antigen Protein-Serine-Threonine Kinases Insulin-Like Growth Factor Binding Protein 3

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Prostatectomy Cause of Death Orchiectomy Early Detection of Cancer Sensitivity and Specificity Prognosis Risk Factors Neoplasm Staging Neoplasm Grading Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Retrospective Studies Xenograft Model Antitumor Assays Follow-Up Studies Digital Rectal Examination Immunohistochemistry Neoplasm Transplantation Biopsy Blotting, Western Transplantation, Heterologous Case-Control Studies Risk Assessment Gene Expression Profiling Risk Treatment Outcome Survival Analysis Survival Rate Reproducibility of Results Predictive Value of Tests Cohort Studies Biopsy, Needle Incidence Transurethral Resection of Prostate Odds Ratio Polymerase Chain Reaction Diagnostic Errors Transfection Oligonucleotide Array Sequence Analysis Registries Diagnostic Imaging Multivariate Analysis Brachytherapy Combined Modality Therapy Tumor Burden Tissue Array Analysis Logistic Models ROC Curve Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival SEER Program Questionnaires Castration Diagnostic Tests, Routine Radiotherapy Mass Screening Models, Biological Drug Screening Assays, Antitumor Molecular Targeted Therapy Diagnostic Techniques and Procedures Nomograms Radiotherapy Dosage Disease Models, Animal Immunoenzyme Techniques Flow Cytometry Radiotherapy, Conformal Clinical Trials as Topic Tomography, X-Ray Computed Confidence Intervals Gene Knockdown Techniques Enzyme-Linked Immunosorbent Assay In Situ Hybridization, Fluorescence Real-Time Polymerase Chain Reaction Magnetic Resonance Imaging Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Chemotherapy, Adjuvant Immunoblotting Positron-Emission Tomography Immunotherapy

Psychiatry and Psychology1

Phenomena and Processes44

Cell Death Gene Expression Regulation, Neoplastic Sensitivity and Specificity Apoptosis Cell Proliferation Genetic Predisposition to Disease Signal Transduction Cell Survival Risk Time Factors Drug Resistance, Neoplasm Cell Growth Processes Down-Regulation Genotype Cell Division Odds Ratio Transfection Mutation Up-Regulation Cell Movement DNA Methylation Dose-Response Relationship, Drug Cell Cycle Promoter Regions, Genetic Polymorphism, Genetic Gene Silencing Base Sequence RNA Interference Nomograms Gene Expression Genes, Tumor Suppressor Gene Fusion Chromosomes, Human, Pair 8 Phosphorylation Polymorphism, Single Nucleotide Phenotype Diet Alleles Transcription, Genetic Genes, Neoplasm Enzyme Activation Drug Synergism Algorithms Germ-Line Mutation

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science12

Cause of Death Survival Rate Incidence Registries SEER Program Questionnaires Molecular Sequence Data Base Sequence Radiotherapy, Conformal Algorithms Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care34

Patient Navigation Cause of Death Sensitivity and Specificity Risk Factors Prospective Studies Retrospective Studies Follow-Up Studies Watchful Waiting Case-Control Studies Risk Assessment Risk Treatment Outcome Survival Analysis Survival Rate Reproducibility of Results Predictive Value of Tests Cohort Studies Incidence Odds Ratio Age Factors Diagnostic Errors Registries Multivariate Analysis Logistic Models ROC Curve Kaplan-Meier Estimate Disease-Free Survival SEER Program Questionnaires National Cancer Institute (U.S.)Mass Screening Nomograms Clinical Trials as Topic Confidence Intervals

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Patient Navigation Prostate Neoplasms Prostatic Neoplasms Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Cell Death Prostatectomy Cause of Death Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Early Detection of Cancer Tumor Markers, Biological Disease Progression Adenocarcinoma Neoplasm Metastasis Mice, Nude Sensitivity and Specificity Prostatic Intraepithelial Neoplasia Apoptosis Tosyl Compounds Bone Neoplasms Prognosis Risk Factors Neoplasm Invasiveness Neoplasm Staging Neoplasm Grading Cell Proliferation Tumor Cells, Cultured Antineoplastic Agents Reverse Transcriptase Polymerase Chain Reaction Genetic Predisposition to Disease Antineoplastic Agents, Hormonal Neoplasm Proteins Prospective Studies Retrospective Studies Androgen Receptor Antagonists Xenograft Model Antitumor Assays Follow-Up Studies Breast Neoplasms RNA, Messenger Digital Rectal Examination Death Immunohistochemistry Anilides Watchful Waiting Neoplasm Transplantation Biopsy Blotting, Western Signal Transduction Dihydrotestosterone Transplantation, Heterologous Case-Control Studies United States Risk Assessment Gene Expression Profiling Lung Neoplasms Cell Survival Risk Finasteride Treatment Outcome Survival Analysis Survival Rate Time Factors Carcinoma Reproducibility of Results Predictive Value of Tests Cohort Studies Biopsy, Needle Neoplasm Recurrence, Local RNA, Small Interfering Incidence Transurethral Resection of Prostate Metribolone Ovarian Neoplasms Drug Resistance, Neoplasm Cell Growth Processes Down-Regulation Genotype Cell Division Prostatic Neoplasms, Castration-Resistant Flutamide Anticarcinogenic Agents Odds Ratio Age Factors Colonic Neoplasms Cancer Vaccines Taxoids Polymerase Chain Reaction Glutamate Carboxypeptidase II Mice, SCID Diagnostic Errors Transfection Oligonucleotide Array Sequence Analysis Registries

No FAQ available that match "deaths prostate cancer diagnostic imaging"